Associated Papers
In silico and biological analyses of missense variants of the human biliary efflux transporter ABCC2: effects of novel rare missense variants.
Kölz C et al.
British Journal of Pharmacology, 2024
A recurrent ABCC2 p.G693R mutation resulting in loss of function of MRP2 and hyperbilirubinemia in Dubin-Johnson syndrome in China.
Wu L et al.
Orphanet Journal of Rare Diseases, 2020
32183854 (PubMed )
Supplement: 13023_2020_1346_MOESM1_ESM.docx
Phenotype prediction of non-synonymous single-nucleotide polymorphisms in human ATP-binding cassette transporter genes.
Wang LL et al.
Basic & Clinical Pharmacology & Toxicology, 2011
Recent development in pharmacogenomics: from candidate genes to genome-wide association studies.
Grant SF et al.
Expert Review of Molecular Diagnostics, 2007
The apical conjugate efflux pump ABCC2 (MRP2).
Nies AT et al.
Pflugers Archiv : European Journal of Physiology, 2007
Role of pharmacogenetics of ATP-binding cassette transporters in the pharmacokinetics of drugs.
Cascorbi I
Pharmacology & Therapeutics, 2006
Identification of a novel 974C-->G nonsense mutation of the MRP2/ABCC2 gene in a patient with Dubin-Johnson syndrome and analysis of the effects of rifampicin and ursodeoxycholic acid on serum bilirubin and bile acids.
Corpechot C et al.
The American Journal of Gastroenterology, 2006
Determinants of the elimination of methotrexate and 7-hydroxy-methotrexate following high-dose infusional therapy to cancer patients.
Joerger M et al.
British Journal of Clinical Pharmacology, 2006
Pharmacogenetic screening for polymorphisms in drug-metabolizing enzymes and drug transporters in a Dutch population.
Bosch TM et al.
Molecular Diagnosis & Therapy, 2006
A mutation in the drug transporter gene ABCC2 associated with impaired methotrexate elimination.
Hulot JS et al.
Pharmacogenetics and Genomics, 2005
Pharmacogenetics and the concept of individualized medicine.
Shastry BS
The Pharmacogenomics Journal, 0
Select a paper to view details